JANX EBITDA Growth
Janux Therapeutics Inc · EBITDA Growth
JANX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported2.77%period ending
JANX TTM EBITDA YoY % (-395.95% → 2.77%)
Year-over-year change
High-resolution chart · PNG
JANX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 2.7694% | |
| -48.6214% | |
| -66.7254% | |
| -70.7614% | |
| -146.71% | |
| -41.3275% | |
| -18.8079% | |
| 3.8109% | |
| 36.5461% | |
| 18.7192% | |
| 9.4506% | |
| -1.4439% | |
| -22.0517% | |
| -51.0903% | |
| -91.0931% | |
| -187.2872% | |
| -376.735% | |
| -479.4977% | |
| -395.9482% |